vs
Side-by-side financial comparison of CF BANKSHARES INC. (CFBK) and ROCKWELL MEDICAL, INC. (RMTI). Click either name above to swap in a different company.
ROCKWELL MEDICAL, INC. is the larger business by last-quarter revenue ($18.3M vs $15.7M, roughly 1.2× CF BANKSHARES INC.). CF BANKSHARES INC. runs the higher net margin — 40.0% vs -3.0%, a 43.1% gap on every dollar of revenue. On growth, CF BANKSHARES INC. posted the faster year-over-year revenue change (12.6% vs -25.6%). CF BANKSHARES INC. produced more free cash flow last quarter ($18.2M vs $2.2M). Over the past eight quarters, CF BANKSHARES INC.'s revenue compounded faster (13.7% CAGR vs -10.1%).
CF Bankshares Inc. is a U.S.-based regional bank holding company operating through its community bank subsidiary. It offers a full suite of personal and commercial banking solutions including deposit products, various loan options, wealth management services and digital banking tools, primarily serving individual consumers and small-to-medium business clients across the U.S. Midwest region.
Rockwell Medical Inc. is a publicly traded pharmaceutical company based in Wixom, Michigan and founded in 1996 that focuses on development and commercialization of treatments against diseases such as end-stage renal disease (ESRD) and chronic kidney disease (CKD).
CFBK vs RMTI — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $15.7M | $18.3M |
| Net Profit | $5.7M | $-554.0K |
| Gross Margin | — | 21.1% |
| Operating Margin | 43.4% | -2.2% |
| Net Margin | 40.0% | -3.0% |
| Revenue YoY | 12.6% | -25.6% |
| Net Profit YoY | 29.9% | 26.7% |
| EPS (diluted) | $0.88 | $-0.01 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $15.7M | $18.3M | ||
| Q3 25 | $15.5M | $15.9M | ||
| Q2 25 | $15.6M | $16.1M | ||
| Q1 25 | $14.1M | $18.9M | ||
| Q4 24 | $14.0M | $24.7M | ||
| Q3 24 | $13.1M | $28.3M | ||
| Q2 24 | $12.6M | $25.8M | ||
| Q1 24 | $12.2M | $22.7M |
| Q4 25 | $5.7M | $-554.0K | ||
| Q3 25 | $2.3M | $-1.8M | ||
| Q2 25 | $5.0M | $-1.5M | ||
| Q1 25 | $4.4M | $-1.5M | ||
| Q4 24 | $4.4M | $-756.0K | ||
| Q3 24 | $4.2M | $1.7M | ||
| Q2 24 | $1.7M | $343.0K | ||
| Q1 24 | $3.1M | $-1.7M |
| Q4 25 | — | 21.1% | ||
| Q3 25 | — | 14.3% | ||
| Q2 25 | — | 15.6% | ||
| Q1 25 | — | 16.1% | ||
| Q4 24 | — | 14.7% | ||
| Q3 24 | — | 22.0% | ||
| Q2 24 | — | 17.6% | ||
| Q1 24 | — | 13.5% |
| Q4 25 | 43.4% | -2.2% | ||
| Q3 25 | 17.5% | -9.9% | ||
| Q2 25 | 41.1% | -8.4% | ||
| Q1 25 | 39.5% | -7.2% | ||
| Q4 24 | 36.9% | -2.1% | ||
| Q3 24 | 40.4% | 6.8% | ||
| Q2 24 | 15.4% | 2.0% | ||
| Q1 24 | 30.9% | -5.8% |
| Q4 25 | 40.0% | -3.0% | ||
| Q3 25 | 15.1% | -11.0% | ||
| Q2 25 | 32.3% | -9.3% | ||
| Q1 25 | 31.4% | -8.0% | ||
| Q4 24 | 35.2% | -3.1% | ||
| Q3 24 | 32.2% | 5.9% | ||
| Q2 24 | 13.5% | 1.3% | ||
| Q1 24 | 25.2% | -7.6% |
| Q4 25 | $0.88 | $-0.01 | ||
| Q3 25 | $0.36 | $-0.05 | ||
| Q2 25 | $0.77 | $-0.05 | ||
| Q1 25 | $0.68 | $-0.04 | ||
| Q4 24 | $0.68 | $-0.02 | ||
| Q3 24 | $0.65 | $0.04 | ||
| Q2 24 | $0.26 | $0.01 | ||
| Q1 24 | $0.47 | $-0.06 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $259.0M | $10.7M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $184.4M | $37.0M |
| Total Assets | $2.1B | $57.1M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $259.0M | $10.7M | ||
| Q3 25 | $272.4M | $13.6M | ||
| Q2 25 | $275.7M | $12.5M | ||
| Q1 25 | $241.0M | $11.4M | ||
| Q4 24 | $235.3M | $15.7M | ||
| Q3 24 | $233.5M | $12.3M | ||
| Q2 24 | $241.8M | $11.9M | ||
| Q1 24 | $236.9M | $6.6M |
| Q4 25 | $184.4M | $37.0M | ||
| Q3 25 | $179.3M | $37.0M | ||
| Q2 25 | $177.0M | $30.4M | ||
| Q1 25 | $172.7M | $31.5M | ||
| Q4 24 | $168.4M | $32.6M | ||
| Q3 24 | $164.0M | $29.1M | ||
| Q2 24 | $159.6M | $23.5M | ||
| Q1 24 | $158.0M | $20.6M |
| Q4 25 | $2.1B | $57.1M | ||
| Q3 25 | $2.1B | $57.5M | ||
| Q2 25 | $2.1B | $52.6M | ||
| Q1 25 | $2.1B | $54.0M | ||
| Q4 24 | $2.1B | $59.2M | ||
| Q3 24 | $2.1B | $57.1M | ||
| Q2 24 | $2.0B | $53.0M | ||
| Q1 24 | $2.0B | $50.7M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $18.7M | $2.3M |
| Free Cash FlowOCF − Capex | $18.2M | $2.2M |
| FCF MarginFCF / Revenue | 115.6% | 12.0% |
| Capex IntensityCapex / Revenue | 3.1% | 0.5% |
| Cash ConversionOCF / Net Profit | 3.26× | — |
| TTM Free Cash FlowTrailing 4 quarters | $33.4M | $-1.2M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $18.7M | $2.3M | ||
| Q3 25 | $5.5M | $-1.3M | ||
| Q2 25 | $8.0M | $1.8M | ||
| Q1 25 | $2.2M | $-3.5M | ||
| Q4 24 | $14.2M | $865.0K | ||
| Q3 24 | $-1.3M | $4.3M | ||
| Q2 24 | $4.0M | $1.4M | ||
| Q1 24 | $-1.2M | $-2.4M |
| Q4 25 | $18.2M | $2.2M | ||
| Q3 25 | $5.2M | $-1.5M | ||
| Q2 25 | $7.8M | $1.7M | ||
| Q1 25 | $2.2M | $-3.5M | ||
| Q4 24 | $13.9M | $470.0K | ||
| Q3 24 | $-1.3M | $4.1M | ||
| Q2 24 | $4.0M | $1.2M | ||
| Q1 24 | $-1.2M | $-2.5M |
| Q4 25 | 115.6% | 12.0% | ||
| Q3 25 | 33.6% | -9.6% | ||
| Q2 25 | 50.3% | 10.5% | ||
| Q1 25 | 15.2% | -18.8% | ||
| Q4 24 | 99.6% | 1.9% | ||
| Q3 24 | -9.9% | 14.4% | ||
| Q2 24 | 31.6% | 4.5% | ||
| Q1 24 | -9.5% | -11.1% |
| Q4 25 | 3.1% | 0.5% | ||
| Q3 25 | 1.7% | 1.4% | ||
| Q2 25 | 0.7% | 1.0% | ||
| Q1 25 | 0.4% | 0.3% | ||
| Q4 24 | 1.9% | 1.6% | ||
| Q3 24 | 0.2% | 0.7% | ||
| Q2 24 | 0.1% | 1.1% | ||
| Q1 24 | 0.0% | 0.6% |
| Q4 25 | 3.26× | — | ||
| Q3 25 | 2.34× | — | ||
| Q2 25 | 1.58× | — | ||
| Q1 25 | 0.50× | — | ||
| Q4 24 | 3.21× | — | ||
| Q3 24 | -0.30× | 2.57× | ||
| Q2 24 | 2.35× | 4.20× | ||
| Q1 24 | -0.38× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
CFBK
Segment breakdown not available.
RMTI
| US | $15.9M | 87% |
| Non Us | $2.4M | 13% |
